FDA Inspection 1278330 — Egis Pharmaceuticals PLC
The FDA completed an inspection of Egis Pharmaceuticals PLC on Jul 5, 2024 in Budapest. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jul 5, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Budapest (Hungary)
Additional Details
Mutual Recognition Agreement (MRA)